ID   AGT2_RAT                Reviewed;         512 AA.
AC   Q64565; O08616; Q642F1;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 2.
DT   27-NOV-2024, entry version 157.
DE   RecName: Full=Alanine--glyoxylate aminotransferase 2, mitochondrial;
DE            Short=AGT 2;
DE            EC=2.6.1.44 {ECO:0000269|PubMed:2123486, ECO:0000269|PubMed:6803844};
DE   AltName: Full=(R)-3-amino-2-methylpropionate--pyruvate transaminase;
DE            EC=2.6.1.40 {ECO:0000269|PubMed:10989446, ECO:0000269|PubMed:2393662, ECO:0000269|PubMed:6803844};
DE   AltName: Full=Beta-ALAAT II {ECO:0000303|PubMed:2393662};
DE   AltName: Full=Beta-alanine-pyruvate aminotransferase;
DE            EC=2.6.1.18 {ECO:0000269|PubMed:10989446};
DE   AltName: Full=D-3-aminoisobutyrate-pyruvate aminotransferase {ECO:0000303|PubMed:2393662};
DE   AltName: Full=D-AIBAT {ECO:0000303|PubMed:10989446};
DE   AltName: Full=D-beta-aminoisobutyrate-pyruvate aminotransferase {ECO:0000303|PubMed:10989446};
DE   Flags: Precursor;
GN   Name=Agxt2; Synonyms=Agt2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Wistar; TISSUE=Kidney;
RX   PubMed=7592550; DOI=10.1093/oxfordjournals.jbchem.a124787;
RA   Matsui-Lee I.S., Muragaki Y., Ideguchi T., Hase T., Tsuji M., Ooshima A.,
RA   Okuno E., Kido R.;
RT   "Molecular cloning and sequencing of a cDNA encoding alanine-glyoxylate
RT   aminotransferase 2 from rat kidney.";
RL   J. Biochem. 117:856-862(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 40-57, FUNCTION, CATALYTIC
RP   ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND
RP   COFACTOR.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=10989446; DOI=10.1016/s0076-6879(00)24247-x;
RA   Tamaki N., Sakata S.F., Matsuda K.;
RT   "Purification, properties, and sequencing of aminoisobutyrate
RT   aminotransferases from rat liver.";
RL   Methods Enzymol. 324:376-389(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=6803844; DOI=10.1016/0304-4165(82)90054-x;
RA   Okuno E., Minatogawa Y., Kido R.;
RT   "Co-purification of alanine-glyoxylate aminotransferase with 2-
RT   aminobutyrate aminotransferase in rat kidney.";
RL   Biochim. Biophys. Acta 715:97-104(1982).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=2393662; DOI=10.1016/0304-4165(90)90106-7;
RA   Ueno S., Sano A., Hineno T., Kondoh K., Mizuno T., Morino H., Kakimoto Y.;
RT   "Further studies on D-3-aminoisobutyrate-pyruvate aminotransferase.";
RL   Biochim. Biophys. Acta 1035:128-131(1990).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, SUBCELLULAR LOCATION,
RP   ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=2123486; DOI=10.1016/s0021-9258(17)45307-5;
RA   Ogawa T., Kimoto M., Sasaoka K.;
RT   "Dimethylarginine:pyruvate aminotransferase in rats. Purification,
RT   properties, and identity with alanine:glyoxylate aminotransferase 2.";
RL   J. Biol. Chem. 265:20938-20945(1990).
CC   -!- FUNCTION: Multifunctional aminotransferase with a broad substrate
CC       specifcity (PubMed:10989446, PubMed:2123486, PubMed:2393662,
CC       PubMed:6803844). Catalyzes the conversion of glyoxylate to glycine
CC       using alanine as the amino donor (PubMed:2123486, PubMed:6803844).
CC       Catalyzes metabolism of not L- but the D-isomer of D-beta-
CC       aminoisobutyric acid to generate 2-methyl-3-oxopropanoate and alanine
CC       (PubMed:10989446, PubMed:2393662, PubMed:6803844). Catalyzes the
CC       transfer of the amino group from beta-alanine to pyruvate to yield L-
CC       alanine and 3-oxopropanoate (PubMed:10989446). Can metabolize NG-
CC       monomethyl-L-arginine (NMMA), asymmetric NG,NG-dimethyl-L-arginine
CC       (ADMA) and symmetric NG,N'G-dimethyl-L-arginine (SDMA)
CC       (PubMed:2123486). ADMA is a potent inhibitor of nitric-oxide (NO)
CC       synthase, and this activity provides mechanism through which the kidney
CC       regulates blood pressure (By similarity).
CC       {ECO:0000250|UniProtKB:Q9BYV1, ECO:0000269|PubMed:10989446,
CC       ECO:0000269|PubMed:2123486, ECO:0000269|PubMed:2393662,
CC       ECO:0000269|PubMed:6803844}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyoxylate + L-alanine = glycine + pyruvate;
CC         Xref=Rhea:RHEA:24248, ChEBI:CHEBI:15361, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:57972; EC=2.6.1.44;
CC         Evidence={ECO:0000269|PubMed:2123486, ECO:0000269|PubMed:6803844};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24249;
CC         Evidence={ECO:0000305|PubMed:6803844};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-3-amino-2-methylpropanoate + pyruvate = 2-methyl-3-
CC         oxopropanoate + L-alanine; Xref=Rhea:RHEA:18393, ChEBI:CHEBI:15361,
CC         ChEBI:CHEBI:57700, ChEBI:CHEBI:57731, ChEBI:CHEBI:57972; EC=2.6.1.40;
CC         Evidence={ECO:0000269|PubMed:10989446, ECO:0000269|PubMed:2393662,
CC         ECO:0000269|PubMed:6803844};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18394;
CC         Evidence={ECO:0000305|PubMed:10989446};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-oxopropanoate + L-alanine = beta-alanine + pyruvate;
CC         Xref=Rhea:RHEA:14077, ChEBI:CHEBI:15361, ChEBI:CHEBI:33190,
CC         ChEBI:CHEBI:57966, ChEBI:CHEBI:57972; EC=2.6.1.18;
CC         Evidence={ECO:0000269|PubMed:10989446};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:14079;
CC         Evidence={ECO:0000305|PubMed:10989446};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxobutanoate + L-alanine = (2S)-2-aminobutanoate + pyruvate;
CC         Xref=Rhea:RHEA:77355, ChEBI:CHEBI:15361, ChEBI:CHEBI:16763,
CC         ChEBI:CHEBI:57972, ChEBI:CHEBI:74359; EC=2.6.1.44;
CC         Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(omega),N(omega)-dimethyl-L-arginine + pyruvate = 5-(3,3-
CC         dimethylguanidino)-2-oxopentanoate + L-alanine; Xref=Rhea:RHEA:77303,
CC         ChEBI:CHEBI:15361, ChEBI:CHEBI:57972, ChEBI:CHEBI:58326,
CC         ChEBI:CHEBI:197301; Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(omega),N('omega)-dimethyl-L-arginine + pyruvate = 5-(3,3'-
CC         dimethylguanidino)-2-oxopentanoate + L-alanine; Xref=Rhea:RHEA:77307,
CC         ChEBI:CHEBI:15361, ChEBI:CHEBI:57972, ChEBI:CHEBI:197308,
CC         ChEBI:CHEBI:197310; Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(omega),N(omega)-dimethyl-L-arginine + glyoxylate = 5-(3,3-
CC         dimethylguanidino)-2-oxopentanoate + glycine; Xref=Rhea:RHEA:77311,
CC         ChEBI:CHEBI:36655, ChEBI:CHEBI:57305, ChEBI:CHEBI:58326,
CC         ChEBI:CHEBI:197301; Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(omega),N('omega)-dimethyl-L-arginine + glyoxylate = 5-(3,3'-
CC         dimethylguanidino)-2-oxopentanoate + glycine; Xref=Rhea:RHEA:77315,
CC         ChEBI:CHEBI:36655, ChEBI:CHEBI:57305, ChEBI:CHEBI:197308,
CC         ChEBI:CHEBI:197310; Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(omega)-methyl-L-arginine + pyruvate = 5-(3-methylguanidino)-
CC         2-oxopentanoate + L-alanine; Xref=Rhea:RHEA:77319, ChEBI:CHEBI:15361,
CC         ChEBI:CHEBI:57972, ChEBI:CHEBI:114953, ChEBI:CHEBI:197314;
CC         Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(omega)-methyl-L-arginine + glyoxylate = 5-(3-
CC         methylguanidino)-2-oxopentanoate + glycine; Xref=Rhea:RHEA:77323,
CC         ChEBI:CHEBI:36655, ChEBI:CHEBI:57305, ChEBI:CHEBI:114953,
CC         ChEBI:CHEBI:197314; Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-ornithine + pyruvate = 5-amino-2-oxopentanoate + L-alanine;
CC         Xref=Rhea:RHEA:77327, ChEBI:CHEBI:15361, ChEBI:CHEBI:46911,
CC         ChEBI:CHEBI:57972, ChEBI:CHEBI:58802;
CC         Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-ornithine + glyoxylate = 5-amino-2-oxopentanoate + glycine;
CC         Xref=Rhea:RHEA:77331, ChEBI:CHEBI:36655, ChEBI:CHEBI:46911,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:58802;
CC         Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2S)-2-aminobutanoate + glyoxylate = 2-oxobutanoate + glycine;
CC         Xref=Rhea:RHEA:77339, ChEBI:CHEBI:16763, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:74359;
CC         Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(omega),N(omega)-dimethyl-L-arginine + oxaloacetate = 5-(3,3-
CC         dimethylguanidino)-2-oxopentanoate + L-aspartate;
CC         Xref=Rhea:RHEA:77343, ChEBI:CHEBI:16452, ChEBI:CHEBI:29991,
CC         ChEBI:CHEBI:58326, ChEBI:CHEBI:197301;
CC         Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=oxaloacetate + L-alanine = L-aspartate + pyruvate;
CC         Xref=Rhea:RHEA:77347, ChEBI:CHEBI:15361, ChEBI:CHEBI:16452,
CC         ChEBI:CHEBI:29991, ChEBI:CHEBI:57972;
CC         Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(omega),N(omega)-dimethyl-L-arginine + 2-oxobutanoate = 5-
CC         (3,3-dimethylguanidino)-2-oxopentanoate + (2S)-2-aminobutanoate;
CC         Xref=Rhea:RHEA:77351, ChEBI:CHEBI:16763, ChEBI:CHEBI:58326,
CC         ChEBI:CHEBI:74359, ChEBI:CHEBI:197301;
CC         Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxopentanoate + N(omega),N(omega)-dimethyl-L-arginine = 5-
CC         (3,3-dimethylguanidino)-2-oxopentanoate + L-2-aminopentanoate;
CC         Xref=Rhea:RHEA:77359, ChEBI:CHEBI:28644, ChEBI:CHEBI:58326,
CC         ChEBI:CHEBI:58441, ChEBI:CHEBI:197301;
CC         Evidence={ECO:0000269|PubMed:2123486};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxohexanoate + N(omega),N(omega)-dimethyl-L-arginine = L-2-
CC         aminohexanoate + 5-(3,3-dimethylguanidino)-2-oxopentanoate;
CC         Xref=Rhea:RHEA:77363, ChEBI:CHEBI:35177, ChEBI:CHEBI:58326,
CC         ChEBI:CHEBI:58455, ChEBI:CHEBI:197301;
CC         Evidence={ECO:0000269|PubMed:2123486};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:10989446, ECO:0000269|PubMed:2123486};
CC   -!- ACTIVITY REGULATION: Inhibited by 5-fluorouracil and 6-fluorouracil
CC       (PubMed:10989446). Inhibited by phenylhydrazine, hydroxylamine, l-
CC       amino-L-proline, para-chloromercuribenzoate and HgCl2 (PubMed:2123486).
CC       {ECO:0000269|PubMed:10989446, ECO:0000269|PubMed:2123486}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.12 mM for D-beta-aminoisobutyrate {ECO:0000269|PubMed:10989446};
CC         KM=1.4 mM for beta-alanine {ECO:0000269|PubMed:10989446};
CC         KM=13.7 uM for N(omega),N('omega)-dimethyl-L-arginine (with pyruvate
CC         as cosubstrate) {ECO:0000269|PubMed:2123486};
CC         KM=11.1 uM for N(omega),N('omega)-dimethyl-L-arginine (with
CC         glyoxylate as cosubstrate) {ECO:0000269|PubMed:2123486};
CC         KM=9.7 uM for N(omega),N(omega)-dimethyl-L-arginine (with pyruvate as
CC         cosubstrate) {ECO:0000269|PubMed:2123486};
CC         KM=8 uM for N(omega)-methyl-L-arginine (with pyruvate as cosubstrate)
CC         {ECO:0000269|PubMed:2123486};
CC         KM=70 uM for L-ornithine (with pyruvate as cosubstrate)
CC         {ECO:0000269|PubMed:2123486};
CC         KM=7.8 uM for L-alanine (with glyoxylate as cosubstrate)
CC         {ECO:0000269|PubMed:2123486};
CC         KM=2.2 uM for pyruvate (with N(omega),N('omega)-dimethyl-L-arginine
CC         as cosubstrate) {ECO:0000269|PubMed:2123486};
CC         KM=2.4 uM for pyruvate (with N(omega),N(omega)-dimethyl-L-arginine as
CC         cosubstrate) {ECO:0000269|PubMed:2123486};
CC         KM=2.5 uM for pyruvate (with N(omega)-methyl-L-arginine as
CC         cosubstrate) {ECO:0000269|PubMed:2123486};
CC         KM=4.1 uM for pyruvate (with L-ornithine as cosubstrate)
CC         {ECO:0000269|PubMed:2123486};
CC         KM=2.9 uM for glyoxylate (with L-alanine as cosubstrate)
CC         {ECO:0000269|PubMed:2123486};
CC         KM=2.1 uM for glyoxylate (with N(omega),N('omega)-dimethyl-L-arginine
CC         as cosubstrate) {ECO:0000269|PubMed:2123486};
CC       pH dependence:
CC         Optimum pH is 9.5 for transamination between L-alanine and
CC         glyoxylate. Optimum pH is 10.0 for the transamination between
CC         dimethylarginines and pyruvate. Optimum pH is 10.5 for the
CC         transamination between L-ornithine and pyruvate.
CC         {ECO:0000269|PubMed:10989446, ECO:0000269|PubMed:2123486};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:10989446,
CC       ECO:0000269|PubMed:2123486}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:2123486,
CC       ECO:0000269|PubMed:2393662}.
CC   -!- TISSUE SPECIFICITY: Expressed in the liver, lung and kidney.
CC       {ECO:0000269|PubMed:2123486, ECO:0000269|PubMed:2393662}.
CC   -!- DEVELOPMENTAL STAGE: Expression is low at birth, increases sharply
CC       thereafter for 10 days, and then subsequently declines to the adult
CC       level. {ECO:0000269|PubMed:2393662}.
CC   -!- SIMILARITY: Belongs to the class-III pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D38100; BAA07281.1; -; mRNA.
DR   EMBL; AB002584; BAA19549.1; -; mRNA.
DR   EMBL; BC081765; AAH81765.1; -; mRNA.
DR   RefSeq; NP_114023.1; NM_031835.2.
DR   AlphaFoldDB; Q64565; -.
DR   SMR; Q64565; -.
DR   STRING; 10116.ENSRNOP00000024035; -.
DR   iPTMnet; Q64565; -.
DR   PhosphoSitePlus; Q64565; -.
DR   PaxDb; 10116-ENSRNOP00000024035; -.
DR   Ensembl; ENSRNOT00000024035.8; ENSRNOP00000024035.5; ENSRNOG00000017821.8.
DR   Ensembl; ENSRNOT00055046650; ENSRNOP00055038288; ENSRNOG00055026998.
DR   Ensembl; ENSRNOT00060035993; ENSRNOP00060029618; ENSRNOG00060020703.
DR   GeneID; 83784; -.
DR   KEGG; rno:83784; -.
DR   AGR; RGD:621767; -.
DR   CTD; 64902; -.
DR   RGD; 621767; Agxt2.
DR   eggNOG; KOG1404; Eukaryota.
DR   GeneTree; ENSGT00940000156125; -.
DR   HOGENOM; CLU_016922_8_0_1; -.
DR   InParanoid; Q64565; -.
DR   OMA; MVPGFKY; -.
DR   OrthoDB; 345661at2759; -.
DR   BRENDA; 2.6.1.40; 5301.
DR   BRENDA; 2.6.1.44; 5301.
DR   Reactome; R-RNO-389661; Glyoxylate metabolism and glycine degradation.
DR   SABIO-RK; Q64565; -.
DR   PRO; PR:Q64565; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000017821; Expressed in adult mammalian kidney and 11 other cell types or tissues.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0047305; F:(R)-3-amino-2-methylpropionate-pyruvate transaminase activity; IDA:UniProtKB.
DR   GO; GO:0008453; F:alanine-glyoxylate transaminase activity; IDA:UniProtKB.
DR   GO; GO:0016223; F:beta-alanine-pyruvate transaminase activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0019265; P:glycine biosynthetic process, by transamination of glyoxylate; ISO:RGD.
DR   GO; GO:0009436; P:glyoxylate catabolic process; ISO:RGD.
DR   GO; GO:0019481; P:L-alanine catabolic process, by transamination; ISO:RGD.
DR   GO; GO:2001299; P:N(omega),N(omega)-dimethyl-L-arginine catabolic process; IDA:UniProtKB.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISO:RGD.
DR   CDD; cd00610; OAT_like; 1.
DR   FunFam; 3.40.640.10:FF:000055; Alanine--glyoxylate aminotransferase 2, mitochondrial; 1.
DR   FunFam; 3.90.1150.10:FF:000105; alanine--glyoxylate aminotransferase 2, mitochondrial isoform X3; 1.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   InterPro; IPR005814; Aminotrans_3.
DR   InterPro; IPR049704; Aminotrans_3_PPA_site.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   PANTHER; PTHR45688; ALANINE--GLYOXYLATE AMINOTRANSFERASE 2, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR45688:SF3; ALANINE--GLYOXYLATE AMINOTRANSFERASE 2, MITOCHONDRIAL; 1.
DR   Pfam; PF00202; Aminotran_3; 1.
DR   PIRSF; PIRSF000521; Transaminase_4ab_Lys_Orn; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
DR   PROSITE; PS00600; AA_TRANSFER_CLASS_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Aminotransferase; Direct protein sequencing; Mitochondrion;
KW   Pyridoxal phosphate; Reference proteome; Transferase; Transit peptide.
FT   TRANSIT         1..39
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:10989446"
FT   CHAIN           40..512
FT                   /note="Alanine--glyoxylate aminotransferase 2,
FT                   mitochondrial"
FT                   /id="PRO_0000001270"
FT   MOD_RES         55
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         69
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         69
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         82
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         260
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         260
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         302
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         348
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         415
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         415
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         418
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         418
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   MOD_RES         452
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UEG6"
FT   CONFLICT        305
FT                   /note="F -> L (in Ref. 1; BAA07281)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        332
FT                   /note="W -> Y (in Ref. 1; BAA07281)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        337..338
FT                   /note="HD -> QA (in Ref. 1; BAA07281)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        435..436
FT                   /note="MV -> WW (in Ref. 1; BAA07281)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        494..496
FT                   /note="FAF -> LAL (in Ref. 1; BAA07281)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   512 AA;  57201 MW;  C35E389789516B5C CRC64;
     MSLAWRTLQK AFYLETSLRI LQMRPSLSCA SRIYVPKLTL HTKHNMPPCD FSPEKYQSLA
     YNHVLEIHKQ HLSPVNTAYF QKPLLLHQGH MEWLFDSEGN RYLDFFSGIV TVGVGHCHPK
     VTAVAKKQMD RLWHTSSVFF HSPMHEYAER LSALLPEPLK VIFLVNSGSE ANDLAMVMAR
     AYSNHTDIIS FRGAYHGCSP YTLGLTNVGI YKMKVPSTIA CQSTMCPDVF RGPWGGSHCR
     DSPVQTVRKC SCAPDGCQAK ERYIEQFKDT LNTSVATSIA GFFAEPIQGV NGVVQYPKEF
     LKEAFALVRE RGGVCIADEV QTGFGRLGSH FWGFQTHDTM PDIVTMAKGI GNGFPMAAVV
     TTPEIASSLA KHLHHFSTFG GSPLACAIGS AVLEVIEEEN LQRNSQEVGT YMLLKFAKLR
     DEFDIVGDVR GKGLMVGIEM VQDKISRQPL PKTEVNQIHE DCKDMGLLVG RGGNFSQTFR
     IAPPMRVTKL EVDFAFEVFR SALTQHMERR AK
//
ID   METW_YEAST              Reviewed;         575 AA.
AC   Q12198; D6VXV0;
DT   23-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   27-NOV-2024, entry version 156.
DE   RecName: Full=Homocysteine/cysteine synthase {ECO:0000250|UniProtKB:P06106};
DE            EC=2.5.1.47 {ECO:0000269|PubMed:36455053};
DE            EC=2.5.1.49 {ECO:0000269|PubMed:36379252, ECO:0000269|PubMed:36455053};
DE   AltName: Full=Hydrogen sulfide utilizing 1 {ECO:0000303|PubMed:36455053};
DE   AltName: Full=O-acetylserine/O-acetylhomoserine sulfhydrylase {ECO:0000250|UniProtKB:P06106};
DE            Short=OAS-OAH SHLase {ECO:0000250|UniProtKB:P06106};
DE            Short=OAS-OAH sulfhydrylase {ECO:0000250|UniProtKB:P06106};
GN   Name=HSU1 {ECO:0000303|PubMed:36455053};
GN   OrderedLocusNames=YLL058W {ECO:0000312|SGD:S000003981};
GN   ORFNames=L0569 {ECO:0000312|SGD:S000003981};
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204511 / S288c / AB972;
RA   Wedler H., Wambutt R.;
RT   "Sequence of a 37 kb DNA fragment from chromosome XII of Saccharomyces
RT   cerevisiae including the subtelomeric region of the left arm.";
RL   Submitted (JAN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169871; DOI=10.1038/387s087;
RA   Johnston M., Hillier L.W., Riles L., Albermann K., Andre B., Ansorge W.,
RA   Benes V., Brueckner M., Delius H., Dubois E., Duesterhoeft A.,
RA   Entian K.-D., Floeth M., Goffeau A., Hebling U., Heumann K.,
RA   Heuss-Neitzel D., Hilbert H., Hilger F., Kleine K., Koetter P., Louis E.J.,
RA   Messenguy F., Mewes H.-W., Miosga T., Moestl D., Mueller-Auer S.,
RA   Nentwich U., Obermaier B., Piravandi E., Pohl T.M., Portetelle D.,
RA   Purnelle B., Rechmann S., Rieger M., Rinke M., Rose M., Scharfe M.,
RA   Scherens B., Scholler P., Schwager C., Schwarz S., Underwood A.P.,
RA   Urrestarazu L.A., Vandenbol M., Verhasselt P., Vierendeels F., Voet M.,
RA   Volckaert G., Voss H., Wambutt R., Wedler E., Wedler H., Zimmermann F.K.,
RA   Zollner A., Hani J., Hoheisel J.D.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XII.";
RL   Nature 387:87-90(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY,
RP   DISRUPTION PHENOTYPE, AND MUTAGENESIS OF LYS-376.
RX   PubMed=36379252; DOI=10.1016/j.jbc.2022.102697;
RA   Van Oss S.B., Parikh S.B., Coelho N.C., Wacholder A., Belashov I.,
RA   Zdancewicz S., Michaca M., Xu J., Kang Y.P., Ward N.P., Yoon S.J.,
RA   McCourt K.M., McKee J., Ideker T., VanDemark A.P., DeNicola G.M.,
RA   Carvunis A.R.;
RT   "On the illusion of auxotrophy: met15Delta yeast cells can grow on
RT   inorganic sulfur thanks to the previously uncharacterized homocysteine
RT   synthase Yll058w.";
RL   J. Biol. Chem. 298:102697-102697(2022).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, INDUCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=36455053; DOI=10.1371/journal.pbio.3001912;
RA   Yu J.S.L., Heineike B.M., Hartl J., Aulakh S.K., Correia-Melo C.,
RA   Lehmann A., Lemke O., Agostini F., Lee C.T., Demichev V., Messner C.B.,
RA   Muelleder M., Ralser M.;
RT   "Inorganic sulfur fixation via a new homocysteine synthase allows yeast
RT   cells to cooperatively compensate for methionine auxotrophy.";
RL   PLoS Biol. 20:e3001912-e3001912(2022).
CC   -!- FUNCTION: Plays a role in inorganic sulfur assimilation during sulfur-
CC       limited conditions; catalyzes the conversion of O-acetyl-L-homoserine
CC       (OAH) into homocysteine in the methionine biosynthesis pathway
CC       (PubMed:36379252, PubMed:36455053). Also catalyzes the conversion of O-
CC       acetylserine (OAS) into cysteine, the last step in the cysteine
CC       biosynthesis pathway (PubMed:36455053). However, it seems that in
CC       S.cerevisiae cysteine biosynthesis occurs exclusively through the
CC       cystathionine pathway and not via direct incorporation of sulfur into
CC       OAS (By similarity). It therefore has no metabolic role in cysteine
CC       biosynthesis and may only have a regulatory role controlling OAS levels
CC       (By similarity). {ECO:0000250|UniProtKB:P06106,
CC       ECO:0000269|PubMed:36379252, ECO:0000269|PubMed:36455053}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O-acetyl-L-homoserine + methanethiol = L-methionine + acetate
CC         + H(+); Xref=Rhea:RHEA:10048, ChEBI:CHEBI:15378, ChEBI:CHEBI:16007,
CC         ChEBI:CHEBI:30089, ChEBI:CHEBI:57716, ChEBI:CHEBI:57844; EC=2.5.1.49;
CC         Evidence={ECO:0000250|UniProtKB:P06106};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O-acetyl-L-homoserine + hydrogen sulfide = L-homocysteine +
CC         acetate; Xref=Rhea:RHEA:27822, ChEBI:CHEBI:29919, ChEBI:CHEBI:30089,
CC         ChEBI:CHEBI:57716, ChEBI:CHEBI:58199; EC=2.5.1.49;
CC         Evidence={ECO:0000269|PubMed:36379252, ECO:0000269|PubMed:36455053};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O-acetyl-L-serine + hydrogen sulfide = L-cysteine + acetate;
CC         Xref=Rhea:RHEA:14829, ChEBI:CHEBI:29919, ChEBI:CHEBI:30089,
CC         ChEBI:CHEBI:35235, ChEBI:CHEBI:58340; EC=2.5.1.47;
CC         Evidence={ECO:0000269|PubMed:36455053};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250|UniProtKB:P06106};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.29 uM for O-acetyl-L-homoserine (OAH) (at 30 degrees Celsius in
CC         potassium phosphate buffer) {ECO:0000269|PubMed:36379252};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de novo
CC       pathway; L-homocysteine from O-acetyl-L-homoserine.
CC       {ECO:0000305|PubMed:36379252, ECO:0000305|PubMed:36455053}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P06106}.
CC   -!- INDUCTION: Induced in sulfur-limiting conditions (at protein level).
CC       {ECO:0000269|PubMed:36455053}.
CC   -!- DISRUPTION PHENOTYPE: Decreases growth during sulfur-limited conditions
CC       (PubMed:36455053). Simultaneous knockout of MET17 results in an
CC       inability to utilize hydrogen sulfide for methionine metabolism, and
CC       toxic accumulation of hydrogen sulfide (PubMed:36379252,
CC       PubMed:36455053). {ECO:0000269|PubMed:36379252,
CC       ECO:0000269|PubMed:36455053}.
CC   -!- MISCELLANEOUS: Present with 2070 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the trans-sulfuration enzymes family. MET7
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z47973; CAA87999.1; -; Genomic_DNA.
DR   EMBL; Z73163; CAA97511.1; -; Genomic_DNA.
DR   EMBL; BK006945; DAA09266.1; -; Genomic_DNA.
DR   PIR; S50962; S50962.
DR   RefSeq; NP_013042.1; NM_001181878.1.
DR   AlphaFoldDB; Q12198; -.
DR   SMR; Q12198; -.
DR   BioGRID; 31257; 52.
DR   STRING; 4932.YLL058W; -.
DR   PaxDb; 4932-YLL058W; -.
DR   PeptideAtlas; Q12198; -.
DR   EnsemblFungi; YLL058W_mRNA; YLL058W; YLL058W.
DR   GeneID; 850668; -.
DR   KEGG; sce:YLL058W; -.
DR   AGR; SGD:S000003981; -.
DR   SGD; S000003981; YLL058W.
DR   VEuPathDB; FungiDB:YLL058W; -.
DR   eggNOG; KOG0053; Eukaryota.
DR   GeneTree; ENSGT00940000176383; -.
DR   HOGENOM; CLU_011302_1_0_1; -.
DR   InParanoid; Q12198; -.
DR   OMA; LACPYVH; -.
DR   OrthoDB; 35837at2759; -.
DR   BioCyc; YEAST:G3O-32157-MONOMER; -.
DR   BioGRID-ORCS; 850668; 3 hits in 10 CRISPR screens.
DR   PRO; PR:Q12198; -.
DR   Proteomes; UP000002311; Chromosome XII.
DR   RNAct; Q12198; protein.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0003962; F:cystathionine gamma-synthase activity; IBA:GO_Central.
DR   GO; GO:0004124; F:cysteine synthase activity; IEA:RHEA.
DR   GO; GO:0003961; F:O-acetylhomoserine aminocarboxypropyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0051009; F:O-acetylhomoserine sulfhydrylase activity; IEA:RHEA.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0071269; P:L-homocysteine biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0000103; P:sulfate assimilation; IMP:UniProtKB.
DR   GO; GO:0006790; P:sulfur compound metabolic process; IMP:SGD.
DR   GO; GO:0006791; P:sulfur utilization; IMP:UniProtKB.
DR   GO; GO:0019346; P:transsulfuration; IBA:GO_Central.
DR   FunFam; 3.90.1150.10:FF:000063; Probable cystathionine gamma-synthase; 1.
DR   FunFam; 3.40.640.10:FF:000175; YLL058W-like protein; 1.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   InterPro; IPR000277; Cys/Met-Metab_PyrdxlP-dep_enz.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   InterPro; IPR051750; Trans-sulfuration_enzymes.
DR   PANTHER; PTHR42699; -; 1.
DR   PANTHER; PTHR42699:SF1; CYSTATHIONINE GAMMA-SYNTHASE-RELATED; 1.
DR   Pfam; PF01053; Cys_Met_Meta_PP; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
PE   1: Evidence at protein level;
KW   Amino-acid biosynthesis; Cytoplasm; Methionine biosynthesis;
KW   Pyridoxal phosphate; Reference proteome; Transferase.
FT   CHAIN           1..575
FT                   /note="Homocysteine/cysteine synthase"
FT                   /id="PRO_0000114782"
FT   MOD_RES         376
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06721"
FT   MUTAGEN         376
FT                   /note="K->A: Abolishes catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:36379252"
SQ   SEQUENCE   575 AA;  64223 MW;  EDE6292C60ADFDC1 CRC64;
     MTEIEFGQPL PSNLDYAVSF GIPTWDSAIG YAEKVPEVIG KMATGYPRYF PQPPVQRLCA
     YFVKKFGRGS ENCRPFPSVN LGLKCFEYVK SVSGPESKAH LEVETVTIKN RGAKTSKEPA
     ELVLTIAAVL ASEEEFETVK EYWKLRGECV SSRLALSVNQ LLDCANHGSE QVLRELEAGV
     FAAKKGEEKA KNLIKGRIVE NRFRPFGLEK KTPNWEGLNL NPNEDVYLVS SGMSAISTAR
     NLLTFWEEKK NSGDSLNKTT SDQKKKPLLC DTVGIFGFPF KDTQVIMTKF GKCKFFGFGN
     SRDVVELQKF LETSKQRILA VFVETPSNPL LNMPDLKKLR SLADQYGFFI VIDDTIGGLN
     VDILPYADIV STSLTKLFNG ASNVMGGSVV LNPKSSLYPY AREYFRSANF EDLLWCEDAI
     VLERNSRDFE DRTLRANANT GILLNDLLLP EEGKICKKIY YPTVTSKETF ENYESVRNER
     GGYGCLFSVA FFNEGDAKAF YDSLKVFKGP SNGTNFTLAC PYVHLAHHSE LEEVSKFGAD
     PNIIRVSVGL EDIQWLLKVF SSALDVVKSR GSKHS
//
ID   ARGD_ECOLI              Reviewed;         406 AA.
AC   P18335; Q2M725;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   27-NOV-2024, entry version 193.
DE   RecName: Full=Acetylornithine/succinyldiaminopimelate aminotransferase {ECO:0000255|HAMAP-Rule:MF_01107, ECO:0000305};
DE            Short=ACOAT {ECO:0000255|HAMAP-Rule:MF_01107, ECO:0000303|PubMed:2199330};
DE            Short=DapATase {ECO:0000255|HAMAP-Rule:MF_01107, ECO:0000303|PubMed:10074354};
DE            Short=Succinyldiaminopimelate transferase {ECO:0000255|HAMAP-Rule:MF_01107};
DE            EC=2.6.1.11 {ECO:0000255|HAMAP-Rule:MF_01107, ECO:0000269|PubMed:10074354};
DE            EC=2.6.1.17 {ECO:0000255|HAMAP-Rule:MF_01107, ECO:0000269|PubMed:10074354};
GN   Name=argD {ECO:0000255|HAMAP-Rule:MF_01107};
GN   Synonyms=dapC {ECO:0000255|HAMAP-Rule:MF_01107}, dtu;
GN   OrderedLocusNames=b3359, JW3322;
OS   Escherichia coli (strain K12).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2199330; DOI=10.1016/0378-1119(90)90440-3;
RA   Heimberg H., Boyen A., Crabeel M., Glansdorff N.;
RT   "Escherichia coli and Saccharomyces cerevisiae acetylornithine
RT   aminotransferase: evolutionary relationship with ornithine
RT   aminotransferase.";
RL   Gene 90:69-78(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-13.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded in the
RT   genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-27 AND 69-77, FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, AND PATHWAY.
RX   PubMed=10074354; DOI=10.1021/bi982574a;
RA   Ledwidge R., Blanchard J.S.;
RT   "The dual biosynthetic capability of N-acetylornithine aminotransferase in
RT   arginine and lysine biosynthesis.";
RL   Biochemistry 38:3019-3024(1999).
CC   -!- FUNCTION: Involved in both the arginine and lysine biosynthetic
CC       pathways. {ECO:0000255|HAMAP-Rule:MF_01107,
CC       ECO:0000269|PubMed:10074354}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(2)-acetyl-L-ornithine + 2-oxoglutarate = N-acetyl-L-
CC         glutamate 5-semialdehyde + L-glutamate; Xref=Rhea:RHEA:18049,
CC         ChEBI:CHEBI:16810, ChEBI:CHEBI:29123, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:57805; EC=2.6.1.11; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_01107, ECO:0000269|PubMed:10074354};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-succinyl-(2S,6S)-2,6-diaminoheptanedioate + 2-oxoglutarate =
CC         (S)-2-succinylamino-6-oxoheptanedioate + L-glutamate;
CC         Xref=Rhea:RHEA:11960, ChEBI:CHEBI:15685, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:58087; EC=2.6.1.17;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01107,
CC         ECO:0000269|PubMed:10074354};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01107,
CC         ECO:0000305|PubMed:10074354};
CC       Note=Binds 1 pyridoxal phosphate per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_01107, ECO:0000305|PubMed:10074354};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.15 mM for N-acetylornithine {ECO:0000269|PubMed:10074354};
CC         KM=0.075 mM for N-succinyldiaminopimelate
CC         {ECO:0000269|PubMed:10074354};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-arginine biosynthesis; N(2)-acetyl-
CC       L-ornithine from L-glutamate: step 4/4. {ECO:0000255|HAMAP-
CC       Rule:MF_01107, ECO:0000305|PubMed:10074354}.
CC   -!- PATHWAY: Amino-acid biosynthesis; L-lysine biosynthesis via DAP
CC       pathway; LL-2,6-diaminopimelate from (S)-tetrahydrodipicolinate
CC       (succinylase route): step 2/3. {ECO:0000255|HAMAP-Rule:MF_01107,
CC       ECO:0000305|PubMed:10074354}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_01107}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01107,
CC       ECO:0000305}.
CC   -!- MISCELLANEOUS: The reaction catalyzed by ACOAT is highly reversible.
CC       This enzyme may also transaminate ornithine.
CC   -!- SIMILARITY: Belongs to the class-III pyridoxal-phosphate-dependent
CC       aminotransferase family. ArgD subfamily. {ECO:0000255|HAMAP-
CC       Rule:MF_01107, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M32796; AAA23480.1; -; Genomic_DNA.
DR   EMBL; U18997; AAA58156.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76384.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77931.1; -; Genomic_DNA.
DR   PIR; B65130; B65130.
DR   RefSeq; NP_417818.1; NC_000913.3.
DR   RefSeq; WP_000963792.1; NZ_SSZK01000008.1.
DR   AlphaFoldDB; P18335; -.
DR   SMR; P18335; -.
DR   BioGRID; 4260742; 10.
DR   DIP; DIP-9138N; -.
DR   IntAct; P18335; 6.
DR   STRING; 511145.b3359; -.
DR   jPOST; P18335; -.
DR   PaxDb; 511145-b3359; -.
DR   EnsemblBacteria; AAC76384; AAC76384; b3359.
DR   GeneID; 947864; -.
DR   KEGG; ecj:JW3322; -.
DR   KEGG; eco:b3359; -.
DR   KEGG; ecoc:C3026_18245; -.
DR   PATRIC; fig|1411691.4.peg.3371; -.
DR   EchoBASE; EB0064; -.
DR   eggNOG; COG4992; Bacteria.
DR   HOGENOM; CLU_016922_10_1_6; -.
DR   InParanoid; P18335; -.
DR   OMA; RSAWDLC; -.
DR   OrthoDB; 9801052at2; -.
DR   PhylomeDB; P18335; -.
DR   BioCyc; EcoCyc:ACETYLORNTRANSAM-MONOMER; -.
DR   BioCyc; MetaCyc:ACETYLORNTRANSAM-MONOMER; -.
DR   UniPathway; UPA00034; UER00020.
DR   UniPathway; UPA00068; UER00109.
DR   PRO; PR:P18335; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IBA:GO_Central.
DR   GO; GO:0003992; F:N2-acetyl-L-ornithine:2-oxoglutarate 5-aminotransferase activity; IDA:EcoliWiki.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IDA:EcoCyc.
DR   GO; GO:0009016; F:succinyldiaminopimelate transaminase activity; IDA:EcoCyc.
DR   GO; GO:0042450; P:arginine biosynthetic process via ornithine; IGI:EcoCyc.
DR   GO; GO:0033359; P:lysine biosynthetic process via diaminopimelate and N-succinyl-2-amino-6-ketopimelate; IGI:EcoCyc.
DR   CDD; cd00610; OAT_like; 1.
DR   FunFam; 3.40.640.10:FF:000004; Acetylornithine aminotransferase; 1.
DR   FunFam; 3.90.1150.10:FF:000009; Succinylornithine transaminase; 1.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   HAMAP; MF_01107; ArgD_aminotrans_3; 1.
DR   InterPro; IPR017652; Ac/SucOrn_transaminase_bac.
DR   InterPro; IPR004636; AcOrn/SuccOrn_fam.
DR   InterPro; IPR005814; Aminotrans_3.
DR   InterPro; IPR049704; Aminotrans_3_PPA_site.
DR   InterPro; IPR050103; Class-III_PLP-dep_AT.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   NCBIfam; TIGR03246; arg_catab_astC; 1.
DR   NCBIfam; TIGR00707; argD; 1.
DR   PANTHER; PTHR11986:SF113; ACETYLORNITHINE_SUCCINYLDIAMINOPIMELATE AMINOTRANSFERASE; 1.
DR   PANTHER; PTHR11986; AMINOTRANSFERASE CLASS III; 1.
DR   Pfam; PF00202; Aminotran_3; 1.
DR   PIRSF; PIRSF000521; Transaminase_4ab_Lys_Orn; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
DR   PROSITE; PS00600; AA_TRANSFER_CLASS_3; 1.
PE   1: Evidence at protein level;
KW   Amino-acid biosynthesis; Aminotransferase; Arginine biosynthesis;
KW   Cytoplasm; Direct protein sequencing; Lysine biosynthesis;
KW   Pyridoxal phosphate; Reference proteome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:10074354,
FT                   ECO:0000269|PubMed:9298646"
FT   CHAIN           2..406
FT                   /note="Acetylornithine/succinyldiaminopimelate
FT                   aminotransferase"
FT                   /id="PRO_0000112743"
FT   BINDING         108..109
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000250|UniProtKB:P40732, ECO:0000255|HAMAP-
FT                   Rule:MF_01107"
FT   BINDING         141
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000250|UniProtKB:P40732, ECO:0000255|HAMAP-
FT                   Rule:MF_01107"
FT   BINDING         144
FT                   /ligand="N(2)-acetyl-L-ornithine"
FT                   /ligand_id="ChEBI:CHEBI:57805"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SHH5, ECO:0000255|HAMAP-
FT                   Rule:MF_01107"
FT   BINDING         226..229
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000250|UniProtKB:P40732, ECO:0000255|HAMAP-
FT                   Rule:MF_01107"
FT   BINDING         283
FT                   /ligand="N(2)-acetyl-L-ornithine"
FT                   /ligand_id="ChEBI:CHEBI:57805"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SHH5, ECO:0000255|HAMAP-
FT                   Rule:MF_01107"
FT   BINDING         284
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000250|UniProtKB:P40732, ECO:0000255|HAMAP-
FT                   Rule:MF_01107"
FT   MOD_RES         255
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:P40732, ECO:0000255|HAMAP-
FT                   Rule:MF_01107"
FT   CONFLICT        245..247
FT                   /note="GVT -> ALA (in Ref. 1; AAA23480)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   406 AA;  43767 MW;  645AA1EBCA442214 CRC64;
     MAIEQTAITR ATFDEVILPI YAPAEFIPVK GQGSRIWDQQ GKEYVDFAGG IAVTALGHCH
     PALVNALKTQ GETLWHISNV FTNEPALRLG RKLIEATFAE RVVFMNSGTE ANETAFKLAR
     HYACVRHSPF KTKIIAFHNA FHGRSLFTVS VGGQPKYSDG FGPKPADIIH VPFNDLHAVK
     AVMDDHTCAV VVEPIQGEGG VTAATPEFLQ GLRELCDQHQ ALLVFDEVQC GMGRTGDLFA
     YMHYGVTPDI LTSAKALGGG FPISAMLTTA EIASAFHPGS HGSTYGGNPL ACAVAGAAFD
     IINTPEVLEG IQAKRQRFVD HLQKIDQQYD VFSDIRGMGL LIGAELKPQY KGRARDFLYA
     GAEAGVMVLN AGPDVMRFAP SLVVEDADID EGMQRFAHAV AKVVGA
//
ID   PLK_GIAIC               Reviewed;         678 AA.
AC   A8BPK8;
DT   24-JAN-2024, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 1.
DT   27-NOV-2024, entry version 97.
DE   RecName: Full=Serine/threonine-protein kinase PLK {ECO:0000255|RuleBase:RU361162, ECO:0000303|PubMed:33789729};
DE            EC=2.7.11.21 {ECO:0000255|RuleBase:RU361162, ECO:0000269|PubMed:33789729};
DE   AltName: Full=GlPLK {ECO:0000303|PubMed:33789729, ECO:0000303|PubMed:35772734};
DE   AltName: Full=Polo-like kinase {ECO:0000255|RuleBase:RU361162, ECO:0000303|PubMed:33789729, ECO:0000303|PubMed:35772734};
DE            Short=PLK {ECO:0000303|PubMed:33789729, ECO:0000303|PubMed:35772734};
GN   Name=plk {ECO:0000303|PubMed:35772734};
GN   ORFNames=GL50803_00104150 {ECO:0000312|EMBL:KAE8303276.1},
GN   GL50803_104150 {ECO:0000312|EMBL:EDO78102.1};
OS   Giardia intestinalis (strain ATCC 50803 / WB clone C6) (Giardia lamblia).
OC   Eukaryota; Metamonada; Diplomonadida; Hexamitidae; Giardiinae; Giardia.
OX   NCBI_TaxID=184922 {ECO:0000312|EMBL:EDO78102.1};
RN   [1] {ECO:0000312|EMBL:EDO78102.1, ECO:0000312|Proteomes:UP000001548}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 50803 / WB clone C6 {ECO:0000312|Proteomes:UP000001548};
RX   PubMed=17901334; DOI=10.1126/science.1143837;
RA   Morrison H.G., McArthur A.G., Gillin F.D., Aley S.B., Adam R.D.,
RA   Olsen G.J., Best A.A., Cande W.Z., Chen F., Cipriano M.J., Davids B.J.,
RA   Dawson S.C., Elmendorf H.G., Hehl A.B., Holder M.E., Huse S.M., Kim U.U.,
RA   Lasek-Nesselquist E., Manning G., Nigam A., Nixon J.E.J., Palm D.,
RA   Passamaneck N.E., Prabhu A., Reich C.I., Reiner D.S., Samuelson J.,
RA   Svard S.G., Sogin M.L.;
RT   "Genomic minimalism in the early diverging intestinal parasite Giardia
RT   lamblia.";
RL   Science 317:1921-1926(2007).
RN   [2] {ECO:0000312|EMBL:KAE8303276.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 50803 / WB clone C6 {ECO:0000312|EMBL:KAE8303276.1};
RA   Xu F., Jex A., Svard S.G.;
RT   "New Giardia intestinalis WB genome in near-complete chromosomes.";
RL   Submitted (JUL-2019) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, SUBCELLULAR LOCATION,
RP   DEVELOPMENTAL STAGE, PTM, DISRUPTION PHENOTYPE, PHOSPHORYLATION AT THR-179
RP   AND THR-183, AND MUTAGENESIS OF 1-MET--ASP-431; LYS-51; THR-179; THR-183
RP   AND 432-PRO--GLU-678.
RC   STRAIN=ATCC 30957 / WB {ECO:0000303|PubMed:33789729};
RX   PubMed=33789729; DOI=10.1186/s13071-021-04687-5;
RA   Park E.A., Kim J., Shin M.Y., Park S.J.;
RT   "A polo-like kinase modulates cytokinesis and flagella biogenesis in
RT   Giardia lamblia.";
RL   Parasit. Vectors 14:182-182(2021).
RN   [4]
RP   FUNCTION, INTERACTION WITH KIN-13, SUBCELLULAR LOCATION,
RP   AUTOPHOSPHORYLATION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 30957 / WB {ECO:0000303|PubMed:35772734};
RX   PubMed=35772734; DOI=10.3347/kjp.2022.60.3.163;
RA   Park E.A., Kim J., Shin M.Y., Park S.J.;
RT   "Kinesin-13, a Motor Protein, is Regulated by Polo-like Kinase in Giardia
RT   lamblia.";
RL   Korean J. Parasitol. 60:163-172(2022).
CC   -!- FUNCTION: Involved in cell cycle (PubMed:33789729, PubMed:35772734).
CC       Involved in cell division (PubMed:33789729). Involved in cytokinesis
CC       (PubMed:33789729). Involved in flagella biogenesis and in regulation of
CC       flagella length in interphase (PubMed:33789729, PubMed:35772734).
CC       Involved in formation of median bodies during interphase
CC       (PubMed:35772734). Phosphorylates Kin-13 in vitro (PubMed:35772734).
CC       Likely regulates microtubule (MT) depolymerizing activity of Kin-13
CC       (PubMed:35772734). {ECO:0000269|PubMed:33789729,
CC       ECO:0000269|PubMed:35772734}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP +
CC         H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.21;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] +
CC         ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.21;
CC         Evidence={ECO:0000255|RuleBase:RU361162,
CC         ECO:0000269|PubMed:33789729};
CC   -!- ACTIVITY REGULATION: Inhibited by GW843286X (GW), an ATP-competitive
CC       inhibitor. Inhibition leads to reduced growth, increased number of
CC       cells with more than four nuclei, increased number of cells with
CC       condensed nuclei, cell cycle arrest at G2/M or G1/S phase depending on
CC       the treatment time with GW, and increased length of membrane-bound
CC       portions of the caudal and anterior flagella.
CC       {ECO:0000269|PubMed:33789729}.
CC   -!- SUBUNIT: Interacts with Kin-13. {ECO:0000269|PubMed:35772734}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium, flagellum
CC       {ECO:0000269|PubMed:33789729, ECO:0000269|PubMed:35772734}. Cytoplasm,
CC       cytoskeleton, flagellum basal body {ECO:0000269|PubMed:33789729,
CC       ECO:0000269|PubMed:35772734}. Cytoplasm, cytoskeleton, flagellum
CC       axoneme {ECO:0000269|PubMed:33789729, ECO:0000269|PubMed:35772734}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:33789729,
CC       ECO:0000269|PubMed:35772734}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:33789729}. Membrane {ECO:0000269|PubMed:33789729}.
CC       Note=Found in both the membrane and the cytoplasmic fractions in
CC       interphase, G1/S and G2/M phases of the cell cycle (PubMed:33789729).
CC       Localizes to basal bodies, flagella, axonemes, adhesive disk and median
CC       bodies of trophozoites in interphase (PubMed:33789729). Remains
CC       localization at the basal bodies in metaphase, anaphase, telophase and
CC       cytokinesis (PubMed:33789729). Localizes also to mitotic spindles and
CC       axonemes in anaphase (PubMed:33789729). Colocalizes with microtubules
CC       (MTs) in the basal bodies, flagella, axonemes and median bodies in
CC       interphase and anaphase (PubMed:33789729). Colocalizes with MTs in the
CC       mitotic spindles present between two separated groups of basal bodies
CC       in anaphase (PubMed:33789729). Colocalizes with centrin in interphase
CC       as well as during cell division (PubMed:33789729). Phosphorylated form
CC       localizes to basal bodies and distinctly to the cytoplasmic portion of
CC       anterior flagella, median bodies, and flagella tips in interphase cells
CC       (PubMed:33789729, PubMed:35772734). Phosphorylated form localizes to
CC       basal bodies and mitotic spindles in dividing cells (PubMed:33789729).
CC       {ECO:0000269|PubMed:33789729, ECO:0000269|PubMed:35772734}.
CC   -!- DEVELOPMENTAL STAGE: Increased expression in interphase and G2/M phase
CC       compared to G1/S phase (at protein level). Phosphorylated form
CC       increases during the G2/M phase. Increased transcriptional expression
CC       in G2/M phase compared to G1/S phase. {ECO:0000269|PubMed:33789729}.
CC   -!- PTM: Autophosphorylated (PubMed:33789729, PubMed:35772734).
CC       Autophosphorylation is critical for its function in cell growth,
CC       cytokinesis and formation of flagella (PubMed:33789729).
CC       {ECO:0000269|PubMed:33789729, ECO:0000269|PubMed:35772734}.
CC   -!- DISRUPTION PHENOTYPE: Morpholino knockdown results in increased number
CC       of cells with more than four nuclei, increased number of cells with
CC       condensed nuclei, time-dependent cell cycle arrest at G2/M or G1/S
CC       phase, and increased length of membrane-bound portions of the caudal,
CC       anterior and ventral flagella (PubMed:33789729). Simultaneous
CC       morpholino knockdown of both PLK and Kin-13 in interphase cells results
CC       in increased length of the caudal and anterior flagella, and to a
CC       lesser extent ventral flagella, and reduced volume of the median body
CC       (PubMed:35772734). {ECO:0000269|PubMed:33789729,
CC       ECO:0000269|PubMed:35772734}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. CDC5/Polo subfamily. {ECO:0000255|RuleBase:RU361162}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AACB02000030; EDO78102.1; -; Genomic_DNA.
DR   EMBL; AACB03000003; KAE8303276.1; -; Genomic_DNA.
DR   RefSeq; XP_001705776.1; XM_001705724.1.
DR   AlphaFoldDB; A8BPK8; -.
DR   SMR; A8BPK8; -.
DR   STRING; 184922.A8BPK8; -.
DR   iPTMnet; A8BPK8; -.
DR   EnsemblProtists; EDO78102; EDO78102; GL50803_104150.
DR   GeneID; 5698661; -.
DR   KEGG; gla:GL50803_00104150; -.
DR   VEuPathDB; GiardiaDB:GL50803_104150; -.
DR   HOGENOM; CLU_000288_46_1_1; -.
DR   InParanoid; A8BPK8; -.
DR   OMA; QRRRTIC; -.
DR   Proteomes; UP000001548; Chromosome 3.
DR   GO; GO:0005930; C:axoneme; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; IDA:UniProtKB.
DR   GO; GO:0097542; C:ciliary tip; IDA:UniProtKB.
DR   GO; GO:1902671; C:left anterior basal body; IDA:UniProtKB.
DR   GO; GO:0097554; C:left anterior flagellum; IDA:UniProtKB.
DR   GO; GO:1902677; C:left caudal basal body; IDA:UniProtKB.
DR   GO; GO:0097560; C:left caudal flagellum; IDA:UniProtKB.
DR   GO; GO:1902673; C:left posteriolateral basal body; IDA:UniProtKB.
DR   GO; GO:0097556; C:left posteriolateral flagellum; IDA:UniProtKB.
DR   GO; GO:1902675; C:left ventral basal body; IDA:UniProtKB.
DR   GO; GO:0097558; C:left ventral flagellum; IDA:UniProtKB.
DR   GO; GO:0097568; C:median body; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:1902672; C:right anterior basal body; IDA:UniProtKB.
DR   GO; GO:0097555; C:right anterior flagellum; IDA:UniProtKB.
DR   GO; GO:1902678; C:right caudal basal body; IDA:UniProtKB.
DR   GO; GO:0097561; C:right caudal flagellum; IDA:UniProtKB.
DR   GO; GO:1902674; C:right posteriolateral basal body; IDA:UniProtKB.
DR   GO; GO:0097557; C:right posteriolateral flagellum; IDA:UniProtKB.
DR   GO; GO:1902676; C:right ventral basal body; IDA:UniProtKB.
DR   GO; GO:0097559; C:right ventral flagellum; IDA:UniProtKB.
DR   GO; GO:0097597; C:ventral disc; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; IEP:UniProtKB.
DR   GO; GO:1902410; P:mitotic cytokinetic process; IMP:UniProtKB.
DR   GO; GO:0140014; P:mitotic nuclear division; IMP:UniProtKB.
DR   GO; GO:1905504; P:negative regulation of motile cilium assembly; IMP:UniProtKB.
DR   GO; GO:1901978; P:positive regulation of cell cycle checkpoint; IMP:UniProtKB.
DR   GO; GO:0031954; P:positive regulation of protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0031114; P:regulation of microtubule depolymerization; IGI:UniProtKB.
DR   CDD; cd13118; POLO_box_1; 1.
DR   CDD; cd13117; POLO_box_2; 1.
DR   FunFam; 3.30.200.20:FF:000042; Aurora kinase A; 1.
DR   Gene3D; 3.30.1120.30; POLO box domain; 2.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR033701; POLO_box_1.
DR   InterPro; IPR033695; POLO_box_2.
DR   InterPro; IPR000959; POLO_box_dom.
DR   InterPro; IPR036947; POLO_box_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24345; SERINE/THREONINE-PROTEIN KINASE PLK; 1.
DR   PANTHER; PTHR24345:SF0; SERINE_THREONINE-PROTEIN KINASE PLK1; 1.
DR   Pfam; PF00069; Pkinase; 2.
DR   Pfam; PF00659; POLO_box; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF82615; Polo-box domain; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50078; POLO_BOX; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell cycle; Cell division; Cell projection; Cilium; Cytoplasm;
KW   Cytoskeleton; Flagellum; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..678
FT                   /note="Serine/threonine-protein kinase PLK"
FT                   /id="PRO_0000459117"
FT   DOMAIN          22..309
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          435..516
FT                   /note="POLO box 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00154"
FT   DOMAIN          563..644
FT                   /note="POLO box 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00154"
FT   REGION          658..678
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        145
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         28..36
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         51
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10141"
FT   MOD_RES         179
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:33789729"
FT   MOD_RES         183
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:33789729"
FT   MUTAGEN         1..431
FT                   /note="Missing: No effect on subcellular localization."
FT                   /evidence="ECO:0000269|PubMed:33789729"
FT   MUTAGEN         51
FT                   /note="K->R: Loss of autophosphorylation. Reduced growth,
FT                   increased number of cells with four or more nuclei,
FT                   increased number of cells with condensed nuclei, and
FT                   increased length of the caudal, anterior and ventral
FT                   flagella."
FT                   /evidence="ECO:0000269|PubMed:33789729"
FT   MUTAGEN         179
FT                   /note="T->A: Substantial decrease in autophosphorylation,
FT                   reduced growth, increased number of cells with four or more
FT                   nuclei, increased number of cells with condensed nuclei,
FT                   and increased length of the caudal, anterior and ventral
FT                   flagella; when associated with A-183."
FT                   /evidence="ECO:0000269|PubMed:33789729"
FT   MUTAGEN         183
FT                   /note="T->A: Substantial decrease in autophosphorylation,
FT                   reduced growth, increased number of cells with four or more
FT                   nuclei, increased number of cells with condensed nuclei,
FT                   and increased length of the caudal, anterior and ventral
FT                   flagella; when associated with A-179."
FT                   /evidence="ECO:0000269|PubMed:33789729"
FT   MUTAGEN         432..678
FT                   /note="Missing: Does not localize to mitotic spindles at
FT                   anaphase. Colocalizes with centrin at basal bodies of the
FT                   dividing cells, however, the basal bodies are positioned
FT                   incorrectly."
FT                   /evidence="ECO:0000269|PubMed:33789729"
SQ   SEQUENCE   678 AA;  77190 MW;  D7D73687676C5688 CRC64;
     MSHSNAPELH PQIVDPFHNV TYRPGKLLGK GGFAYVYEFH DVNSDSSYAC KITPRSALQK
     KKYYDKFVTE VTIHRGLVHP NICRVLNVFK DQMNYYIILE KCNGGTLTDL IRRRKHLTET
     EARFFSKRIL NALWYLHDLY IIHRDIKTSN IFLMEDFDVK VGDFGLAVKC ETPEELHWTM
     CGTPNFLPSE VIYSHIMKRK ASGRGPDPNL DEDCVNLCHQ LLPAYSGQGH SFSADMWSFG
     CLVFSMIYGR PPFEAADIKT TYKRIVRCDF SFPGSISVSE DLKNFIKGLL TPDPRKRFTV
     KECLDHSWLN PSKYFIPESL PPRIISEPYE VPPLCSASPT RNMQMTINMA KNAGGTDGRF
     IAATPQAIGG TEHIPTPGTA NFYKPQNAIL TTKSAAGISR ASTAMAMQNV GSAQGVVNKY
     GINEAEYPQI DPPCYIMSWV DYSNRYGFAY QISNGSIGVI FNDESAAILS PNALIVDYSP
     SLLDAAFDRA LFEEGTTILS EKKFKLLSFF RDYLENRSIV PIPAADRPKE DEELKRVIEQ
     ERMNNQEIDF KRLTKGLPLP QLFLKKWKLY DDGTLCLLFN TKVFQVNFAD HSKVVVAHRS
     VTFMSEKREI YTYPSEYLKD DRFSFKELRR RVDRARKYYE IIKAARPVDS LAQYRYNKDS
     TKKSASGSST RQLGQGGE
//
